
Pliant Therapeutics, Inc.
PLRXNasdaqCIK 1746473HealthcareFiscal year ends Dec 31
Reports and events: 106 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-11-1016:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-052983 |
| 2020-08-1116:24 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-039327 |
| 2020-08-1116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-039317 |
| 2020-06-0206:08 ET | S-1/A | Registration statement, amended | 0001193125-20-157787 |
| 2020-05-2606:14 ET | S-1/A | Registration statement, amended | 0001193125-20-150643 |
| 2020-05-1121:49 ET | S-1 | Registration statement | 0001193125-20-137876 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.